TrialClinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Trial details
- Registry ID
- NCT02781883
- Phase
- Phase 2
Drug research
BP1001 plus decitabine
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as L-Grb-2; Liposomal Grb-2
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLNCT02781883 | Bio-Path Holdings, Inc. | Phase 2 | Recruiting | 2027-12Estimated |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |